114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster II

A Phase 2 Prospective Randomized Trial of Topical Sodium Nitrite in Patients with Sickle Cell Disease and Leg Ulcers

Barriers and Enablers to Hydroxyurea Adherence in Children and Adolescents with Sickle Cell Disease in Jos, Nigeria

Buprenorphine Is Associated with Lower Home Opioid Use and Acute Care Utilization in Sickle Cell Disease

Combined Red Cell and Plasma Exchange Is Associated with Reduced Mortality of Fat Embolism Syndrome in Sickle Cell Disease

Comparative Efficacy and Safety of Iron Chelators in Sickle Cell Disease: A Meta-Analysis

Defibrotide Reduces Hypercoagulable State in Patients with Sickle Cell Disease-Related Acute Chest Syndrome (IND 127812)

Duffy Status and Hydroxyurea Dosing in Adult Patients with Sickle Cell Disease: A Potential for Iatrogenic Harm?

Effects of Splenomegaly in Children with Sickle Cell Anemia Treated with Hydroxyurea: Secondary Analysis of the Sphere Trial

Evaluating the Effect of Hydroxyurea on Fertility in Individuals Identifying As Women

Evaluation of Sleep Apnea in Adult Sickle Cell Disease; About 107 SS and Sβ°Thal Patients

Hidden Dangers: Pulmonary Embolism Risk in Sickle Cell Trait – Insights from the NIS Database 2020

Improvement in Cerebral Vasoreactivity after 6 Months of Voxelotor Measured By Near-Infrared Spectroscopy (NIRS) in Sickle Cell Disease Patients

Improvement in Kidney Function after 6 Months of Voxelotor in Sickle Cell Disease Patients

Learner- Low Dose Aspirin Preterm Trial (Angola). Low Dose Aspirin in Pregnant Women with Sickle Cell Disease When Started in the First Versus Second Trimester– a Clinical Control Study in Angola

Osteopathic Medical Treatment Improves Pain and Constipation in Children and Adolescents with Sickle Cell Disease

Parameters Associated with Improved Peripheral Oxygen Extraction in Sickle Cell Patients Treated with Voxelotor

Procalcitonin Levels Predict Bacterial Infections and Clinical Outcomes in Adults with Sickle Cell Disease

Results from a Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Tebapivat (AG-946) in Patients with Sickle Cell Disease

Self-Administered Acupressure Improves Pain and Quality of Life in Patients with Sickle Cell Disease

The Impact of Vaccination on COVID-19 Infections and Hospitalizations in Individuals with Sickle Cell Disease

The Pulmonary Embolism Rule-out Criteria (PERC) to Rule out Acute Pulmonary Embolism in Patients with Sickle Cell Disease: A Retrospective Cohort Study

Tracking Entire Units of Transfused Pathogen-Reduced Red Cells in Sickle Cell Patients Using a Novel Acridine Marker

Triaging Acute Chest Syndrome Clinical Decision-Making Using Bedside SaO2/FiO2 Ratio

Voxelotor Impact after 6 Months on Blood Rheology in Patients with Sickle Cell Disease